Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor

Viruses have evolved a myriad of evasion strategies focused on undermining chemokine-mediated immune surveillance, exemplified by the mouse γ-herpesvirus 68 M3 decoy receptor. Crystal structures of M3 in complex with C chemokine ligand 1/lymphotactin and CC chemokine ligand 2/monocyte chemoattractant protein 1 reveal that invariant chemokine features associated with G protein–coupled receptor binding are primarily recognized by the decoy C-terminal domain, whereas the N-terminal domain (NTD) reconfigures to engage divergent basic residue clusters on the surface of chemokines. Favorable electrostatic forces dramatically enhance the association kinetics of chemokine binding by M3, with a primary role ascribed to acidic NTD regions that effectively mimic glycosaminoglycan interactions. Thus, M3 employs two distinct mechanisms of chemical imitation to potently sequester chemokines, thereby inhibiting chemokine receptor binding events as well as the formation of chemotactic gradients necessary for directed leukocyte trafficking.

[1]  T. Lohman,et al.  Kinetics of protein-nucleic acid interactions: use of salt effects to probe mechanisms of interaction. , 1986, CRC critical reviews in biochemistry.

[2]  G Schreiber,et al.  Predicting the rate enhancement of protein complex formation from the electrostatic energy of interaction. , 1999, Journal of molecular biology.

[3]  K. Jarnagin,et al.  Monomeric Monocyte Chemoattractant Protein-1 (MCP-1) Binds and Activates the MCP-1 Receptor CCR2B* , 1998, The Journal of Biological Chemistry.

[4]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[5]  A. Trkola,et al.  The BBXB Motif of RANTES Is the Principal Site for Heparin Binding and Controls Receptor Selectivity* , 2001, The Journal of Biological Chemistry.

[6]  A. Alcamí,et al.  Glycoprotein G isoforms from some alphaherpesviruses function as broad‐spectrum chemokine binding proteins , 2003, The EMBO journal.

[7]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[8]  J. Mccammon,et al.  Electrostatic Influence on the Kinetics of Ligand Binding to Acetylcholinesterase , 1997, The Journal of Biological Chemistry.

[9]  Daved H. Fremont,et al.  Structural Determinants of Chemokine Binding by an Ectromelia Virus-Encoded Decoy Receptor , 2006, Journal of Virology.

[10]  T. Shenk,et al.  Human cytomegalovirus encodes a highly specific RANTES decoy receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Stewart,et al.  Differential Activation of Murine Herpesvirus 68- and Kaposi's Sarcoma-Associated Herpesvirus-Encoded ORF74 G Protein-Coupled Receptors by Human and Murine Chemokines , 2004, Journal of Virology.

[12]  G. J. Swaminathan,et al.  Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine. , 2003, Structure.

[13]  M. Mack,et al.  Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System , 2004, The Journal of Immunology.

[14]  Ronald Breslow,et al.  Molecular recognition , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Isern,et al.  Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1β , 2006, Proceedings of the National Academy of Sciences.

[16]  A. Fersht,et al.  Rapid, electrostatically assisted association of proteins , 1996, Nature Structural Biology.

[17]  T. Handel,et al.  Identification of the Glycosaminoglycan Binding Site of the CC Chemokine, MCP-1 , 2004, Journal of Biological Chemistry.

[18]  R. Linhardt,et al.  Role of glycosaminoglycans in cellular communication. , 2004, Accounts of chemical research.

[19]  Margarida Saraiva,et al.  A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D G Myszka,et al.  Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data. , 1998, Biophysical journal.

[21]  D. Wiley,et al.  Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Doherty,et al.  Cytokine production in the immune response to murine gammaherpesvirus 68 , 1996, Journal of virology.

[23]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[24]  A. Imberty,et al.  A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization. , 2002, Biochemistry.

[25]  E. H ckel,et al.  Zur Theorie der Elektrolyte , 1924 .

[26]  Antonio Alcami,et al.  Viral mechanisms of immune evasion , 2000, Immunology Today.

[27]  T. Lohman,et al.  Energetics of DNA end binding by E.coli RecBC and RecBCD helicases indicate loop formation in the 3'-single-stranded DNA tail. , 2005, Journal of molecular biology.

[28]  M. Lawrence,et al.  Shape complementarity at protein/protein interfaces. , 1993, Journal of molecular biology.

[29]  A. Imberty,et al.  Structural diversity of heparan sulfate binding domains in chemokines , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Chemokines and viruses: the dearest enemies. , 2000 .

[31]  L. Nieba,et al.  Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics. , 1996, Analytical biochemistry.

[32]  G. McFadden,et al.  VIRAL CHEMOKINE-BINDING PROTEINS INHIBIT INFLAMMATORY RESPONSES AND AORTIC ALLOGRAFT TRANSPLANT VASCULOPATHY IN RAT MODELS , 2004, Transplantation.

[33]  A. Alcamí,et al.  Disruption of CCL21-Induced Chemotaxis In Vitro and In Vivo by M3, a Chemokine-Binding Protein Encoded by Murine Gammaherpesvirus 68 , 2003, Journal of Virology.

[34]  C. Bertozzi,et al.  Chemical synthesis of lymphotactin: a glycosylated chemokine with a C-terminal mucin-like domain. , 2001, Chemistry.

[35]  A. Alcamí,et al.  Viral mechanisms of immune evasion , 2000, Immunology Today.

[36]  Thomas C Terwilliger,et al.  Using prime-and-switch phasing to reduce model bias in molecular replacement. , 2004, Acta crystallographica. Section D, Biological crystallography.

[37]  P. Schuck,et al.  Reliable determination of binding affinity and kinetics using surface plasmon resonance biosensors. , 1997, Current opinion in biotechnology.

[38]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[39]  P. Latreille,et al.  Copyright © 1997, American Society for Microbiology Complete Sequence and Genomic Analysis of Murine , 1997 .

[40]  L. Rogers,et al.  Lysine 58 and Histidine 66 at the C-terminal α-Helix of Monocyte Chemoattractant Protein-1 Are Essential for Glycosaminoglycan Binding* , 1998, The Journal of Biological Chemistry.

[41]  A. Alcamí,et al.  The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  D. Spillmann,et al.  Defining the Interleukin-8-binding Domain of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.

[43]  A. Luster,et al.  CXCR3 and Heparin Binding Sites of the Chemokine IP-10 (CXCL10)* , 2003, The Journal of Biological Chemistry.

[44]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[45]  J. Thornton,et al.  Satisfying hydrogen bonding potential in proteins. , 1994, Journal of molecular biology.

[46]  K. Jarnagin,et al.  Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. , 1999, Biochemistry.

[47]  G. McFadden,et al.  The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. , 1997, Virology.

[48]  A. Alcamí,et al.  A Broad Spectrum Secreted Chemokine Binding Protein Encoded by a Herpesvirus , 2000, Journal of Experimental Medicine.

[49]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Timothy N. C. Wells,et al.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Jorge Navaza,et al.  [33] AMoRe: An automated molecular replacement program package. , 1997, Methods in enzymology.

[52]  P. Lusso Chemokines and viruses: the dearest enemies. , 2000, Virology.

[53]  W. Kabsch A solution for the best rotation to relate two sets of vectors , 1976 .

[54]  S. Kunkel,et al.  Elevated Chemokine Responses Are Maintained in Lungs after Clearance of Viral Infection , 2002, Journal of Virology.

[55]  H. Virgin,et al.  Identification and Initial Characterization of the Murine Gammaherpesvirus 68 Gene M3, Encoding an Abundantly Secreted Protein , 1999, Journal of Virology.

[56]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[57]  L. Stern,et al.  Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro. , 1999, Protein expression and purification.

[58]  Menico Rizzi,et al.  Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES , 2001, Nature Structural Biology.

[59]  N. Skelton,et al.  Structure of a CXC chemokine-receptor fragment in complex with interleukin-8. , 1999, Structure.

[60]  Antonio Alcami,et al.  Viral mimicry of cytokines, chemokines and their receptors , 2003, Nature Reviews Immunology.

[61]  D. Fremont,et al.  The Chemokine Binding Protein M3 Prevents Diabetes Induced by Multiple Low Doses of Streptozotocin1 , 2007, The Journal of Immunology.

[62]  J. Esko,et al.  Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. , 1987, The Journal of biological chemistry.

[63]  Li Zhang Structural study of the interaction between poxvirus-encoded cc chemokine inhibitor vcci and human mip-1beta , 2008 .

[64]  D. Fremont,et al.  Identification of a Gammaherpesvirus Selective Chemokine Binding Protein That Inhibits Chemokine Action , 2000, Journal of Virology.

[65]  P. Murphy International Union of Pharmacology. XXX. Update on Chemokine Receptor Nomenclature , 2002, Pharmacological Reviews.

[66]  A. Alcamí,et al.  Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3. , 2004, The American journal of pathology.

[67]  J M Thornton,et al.  Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. , 1991, Journal of molecular biology.

[68]  R. Linhardt,et al.  Identification and Characterization of a Glycosaminoglycan Recognition Element of the C Chemokine Lymphotactin* , 2004, Journal of Biological Chemistry.

[69]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[70]  Tracy M. Handel,et al.  Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[71]  D. Beeler,et al.  6-O-Sulfotransferase-1 Represents a Critical Enzyme in the Anticoagulant Heparan Sulfate Biosynthetic Pathway* , 2001, The Journal of Biological Chemistry.

[72]  J. Markley,et al.  Structural Rearrangement of Human Lymphotactin, a C Chemokine, under Physiological Solution Conditions* , 2002, The Journal of Biological Chemistry.

[73]  Elias Lolis,et al.  Structure, function, and inhibition of chemokines. , 2002, Annual review of pharmacology and toxicology.

[74]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[75]  C. Zwahlen,et al.  The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. , 2004, Structure.

[76]  P. Stevenson,et al.  A γ‐herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope , 2002, European journal of immunology.

[77]  P. Schuck,et al.  Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules. , 1997, Annual review of biophysics and biomolecular structure.

[78]  Victor van Berkel,et al.  Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. , 2002, The Journal of clinical investigation.

[79]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[80]  Tracy M. Handel,et al.  Structural Basis of Chemokine Sequestration by a Herpesvirus Decoy Receptor , 2002, Cell.

[81]  A. Minton,et al.  Analysis of mass transport-limited binding kinetics in evanescent wave biosensors. , 1996, Analytical biochemistry.